# Urine-DNA Biomarkers in Detecting Bladder Cancer

> **NCT03066310** · — · COMPLETED · sponsor: **Xiangya Hospital of Central South University** · enrollment: 125 (actual)

## Conditions studied

- Bladder Cancer
- Biomarker
- Diagnosis
- Urine

## Interventions

- **DIAGNOSTIC_TEST:** Next generation sequencing

## Key facts

- **NCT ID:** NCT03066310
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-17
- **Primary completion:** 2020-01-05
- **Final completion:** 2020-01-10
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2022-11-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03066310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03066310, "Urine-DNA Biomarkers in Detecting Bladder Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03066310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*